First study on quantitative bioanalysis of natural and synthetic cannabinoids by DBS/VAMS-LC–MS/MS. Performance comparison between DBS and VAMS strategies. Data adherence between capillary and venous DBS/VAMS and between dried samples and plasma analysis. Haematocrit issues carefully studied and effectively addressed. Advances and improvements in the monitoring of new psychoactive compounds.